UGT2B17 expression correlated with the expression of several IRFs, with IRF1 and IRF9 transcriptional activity, as well as several gene targets of IRFs, including IRF4 associated with poor CLL survival namely by controlling responsiveness to BCR stimulation in CLL [42]. This evidence concerns the gene UGT2B17 and B-cell chronic lymphocytic leukemia.